Effect of Manual Therapy After Trigger Point Injection for Myofascial Pain Syndrome
Effect of Manual Therapy After Trigger Point Injection for Myofascial Pain Syndrome
This study is a pain intensity evaluation in patients with myofascial pain submitted kinesitherapy after trigger point injection.
Randomized prospective study conducted on 30 patients of both genders ranging in age from 18 to 60 years, with neck and shoulder girdle Myofascial Pain Syndrome (MFS), with a duration of ≥ 4 months and pain intensity ≥ 4.
Trigger point injection of 1 mL 0.25% bupivacaine at each point, once a week for 8 weeks (T1 to T8).
Group 1: kinesiotherapy once a week for 8 weeks Group 2: not submitted to kinesiotherapy Evaluation of pain intensity on the first assessment (T0) and after 1, 2, 3, 4, 5, 6, 7, 8, and 9 weeks
Inclusion Criteria:
Exclusion Criteria: